174 related articles for article (PubMed ID: 36357534)
1. Proteome-Based Investigation Identified Potential Drug Repurposable Small Molecules Against Monkeypox Disease.
Bhattacharjee A; Ahammad I; Chowdhury ZM; Das KC; Keya CA; Salimullah M
Mol Biotechnol; 2024 Apr; 66(4):626-640. PubMed ID: 36357534
[TBL] [Abstract][Full Text] [Related]
2. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
[TBL] [Abstract][Full Text] [Related]
4. A review on computational studies and bioinformatics analysis of potential drugs against monkeypox virus.
Hossain FMA; Bappy MNI; Robin TB; Ahmad I; Patel H; Jahan N; Rabbi MGR; Roy A; Chowdhury W; Ahmed N; Prome AA; Rani NA; Khan P; Zinnah KMA
J Biomol Struct Dyn; 2024 Aug; 42(12):6091-6107. PubMed ID: 37403283
[TBL] [Abstract][Full Text] [Related]
5. Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus.
Rout M; Dey S; Mishra S; Panda S; Singh MK; Sinha R; Dehury B; Pati S
J Biomol Struct Dyn; 2024 May; 42(8):3935-3948. PubMed ID: 37221882
[TBL] [Abstract][Full Text] [Related]
6. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
7. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
[TBL] [Abstract][Full Text] [Related]
8. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.
Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R
Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493
[TBL] [Abstract][Full Text] [Related]
9. Update on monkeypox virus infection: Focusing current treatment and prevention approaches.
Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D
Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405
[TBL] [Abstract][Full Text] [Related]
10. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
[TBL] [Abstract][Full Text] [Related]
11.
Lokhande KB; Shrivastava A; Singh A
J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
[TBL] [Abstract][Full Text] [Related]
12. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I.
Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105
[TBL] [Abstract][Full Text] [Related]
13. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
[TBL] [Abstract][Full Text] [Related]
14. A multi-targeted computational drug discovery approach for repurposing tetracyclines against monkeypox virus.
Alandijany TA; El-Daly MM; Tolah AM; Bajrai LH; Khateb AM; Kumar GS; Dubey A; Dwivedi VD; Azhar EI
Sci Rep; 2023 Sep; 13(1):14570. PubMed ID: 37666979
[TBL] [Abstract][Full Text] [Related]
15. Identification of
Chiem K; Nogales A; Lorenzo M; Morales Vasquez D; Xiang Y; Gupta YK; Blasco R; de la Torre JC; Martínez-Sobrido L
Microbiol Spectr; 2023 Aug; 11(4):e0474522. PubMed ID: 37278625
[TBL] [Abstract][Full Text] [Related]
16. Computational Repurposing of Mitoxantrone-Related Structures against Monkeypox Virus: A Molecular Docking and 3D Pharmacophore Study.
Preet G; Oluwabusola ET; Milne BF; Ebel R; Jaspars M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430762
[TBL] [Abstract][Full Text] [Related]
17. Contriving multi-epitope vaccine ensemble for monkeypox disease using an immunoinformatics approach.
Aziz S; Almajhdi FN; Waqas M; Ullah I; Salim MA; Khan NA; Ali A
Front Immunol; 2022; 13():1004804. PubMed ID: 36311762
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Prevention and Management of Monkeypox Viral Infection in Humans.
Gujjar P; Chaudhay R; Verma I; Bansal N; Gupta S; Bansal S
Curr Drug Targets; 2023; 24(13):1032-1045. PubMed ID: 37842888
[TBL] [Abstract][Full Text] [Related]
19. Expression analysis and mapping of Viral-Host Protein interactions of Poxviridae suggests a lead candidate molecule targeting Mpox.
Loganathan T; Fletcher J; Abraham P; Kannangai R; Chakraborty C; El Allali A; Alsamman AM; Zayed H; C GPD
BMC Infect Dis; 2024 May; 24(1):483. PubMed ID: 38730352
[TBL] [Abstract][Full Text] [Related]
20. Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T
Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
